July 31, 2014     Japanese 
  JCN 
	  Network - Home
JCN Newswire
  Home  |  Companies  | Annual Reports  |  CSR  | News Alerts     
Company
News Sectors
Automotive
Communications
Consumers
CSR
Electronics
Energy
Environment
Financial
Health & Med
Industrial
IT & Internet
Materials
Real Estate
Science & Research
Telecoms
Trade
Transportation
Departments
Annual Reports
Companies
News Alerts
News Search
Photo Gallery
Company Login
Japan Corporate News Network
About JCN
Privacy Policy
RSS  
Terms of Use
 
 
News Search

The results of your word search

Headline News

Eisai Launches Programs to Help Eliminate Lymphatic Filariasis By 2020 (Jan 31, 2012)

Eisai and Apollo Hospitals, HelpAge India to Improve Access to Medicines in India (Jan 18, 2011)

Eisai's New Sales Subsidiary in Canada (May 11, 2010)

Eisai to Sell Catheter Subsidiary to Terumo (June 19, 2008)

Takeda, Eisai Log Recurring Profit Falls in FY '07 (May 14, 2008)

Eisai Launches Sales Support Firm for Pharm. Machines in China (May 7, 2008)

M's Science and Eisai Sign Option Agreement for Sigma Agonist SA4503 (Mar 12, 2008)

Eisai Aiming to Achieve 1.5-T.-Yen Sales by FY 2016 (Mar 4, 2008)

Eisai to Buy Out U.S. Drug Maker MGI Pharma (Dec 10, 2007)

Eisai to Sell Kissei's Insulin Secretagogue in China (Sept 28, 2007)

more...
Press Release News

EMA Grants Eisai's Anticancer Agent Lenvatinib Request for Accelerated Assessment (July 31, 2014)

Eisai Receives European Commission Approval of Indication Expansion for Anticancer Agent Halaven for Advanced Breast Cancer After Only One Prior Chemotherapy (July 3, 2014)

Eisai to Launch First Chocola BB Brand Product "Chocola BB Royal Drink" in China (July 2, 2014)

Eisai Submits First Marketing Authorization Application for Anticancer Agent Lenvatinib in Japan (June 27, 2014)

Phase Iii Trial of Antiepileptic Drug Fycompa (Perampanel) Meets Primary Endpoints (June 17, 2014)

Eisai Honored with Prestigious 'UCL Enterprise Partner Of The Year 2014' Award By University College London (UCL) (May 30, 2014)

Antiemetic Agent Aloxi Approved for Children by the U.S. FDA (May 29, 2014)

Eisai Receives Positive Opinion from EMA's CHMP on Expanding (May 27, 2014)

Eisai to Launch Chocola BB Sparkling Salty Natsumikan Flavor (May 27, 2014)

Eisai's R&D Subsidiary Kan Research Institute Commences Full-Scale Operation at New Facility (May 26, 2014)

more...
 
CSR Report Download
Most Popular


About JCN | Privacy Policy | Terms of Use | JCN Network (日本語)